Postoperative Opioid and Respiratory Depression in Opioid Naive and Chronic Opioid Patients

CompletedOBSERVATIONAL
Enrollment

691

Participants

Timeline

Start Date

October 1, 2023

Primary Completion Date

January 1, 2024

Study Completion Date

January 16, 2024

Conditions
Medical Complication
Interventions
DEVICE

Continuous vital sign monitoring

Wireless monitoring system that provided continuous, non-invasive collection of their vital signs, including peripheral oxygen saturation (SpO2) and respiratory rate (RR), for up to 92 hours following surgery or until discharge. The respiratory rate was monitored via FDA-approved Isansys Lifetouch electrocardiogram (ECG) patch, which was placed on the left side of the chest. SpO2 levels were continuously recorded using the Nonin WristOx 3150, a wrist-mounted finger oximeter.

Trial Locations (2)

2100

Rigshospitalet, Copenhagen

2400

Bispebjerg Hospital, Copenhagen

All Listed Sponsors
collaborator

Bispebjerg Hospital

OTHER

lead

Rigshospitalet, Denmark

OTHER

NCT06227208 - Postoperative Opioid and Respiratory Depression in Opioid Naive and Chronic Opioid Patients | Biotech Hunter | Biotech Hunter